Skip to main content



20 December 2017

New report reveals insights into clinical trials in Australia

A new report reveals Australia ranks in the top tier of national clinical trial activity with more than 10,000 clinical trials conducted between 2006-2015, with cancer the most frequently studied health issue.
19 December 2017

Professor Jennifer Byrne named in Nature journal's top 10

Professor Byrne is the only Australian researcher named in international journal Nature's Top 10 academics of 2017 for her work identifying research papers that could mislead researchers working on cancer treatments.
01 December 2017

Screening for cervical cancer to be revolutionised with HPV testing

University of Sydney molecular biology researcher Professor Brian Morris' innovation used in new cervical screening program to be rolled out in Australia from today.

23 November 2017

New institute to revolutionise cancer imaging and targeted radiotherapy

The Australian Cancer Research Foundation (ACRF) Image X Institute, lead by Professor Paul Keall, will revolutionise medical imaging, transform targeted radiotherapy and enable global access to radiotherapy.

16 November 2017

Researcher wins grant to boost pancreatic survival rates

Australia's leading pancreatic cancer researchers are working to double the number of people who survive the disease by 2020.

09 October 2017

A bequest that has transformed research into liver disease

Before Robert Storr passed away from liver cancer in 1992, he pledged his support for medical research into this devastating illness and its treatment.

04 October 2017

New Executive Dean of Faculty of Medicine and Health

The University of Sydney has appointed Professor Robyn Ward AM FAHMS as the Executive Dean of the new Faculty of Medicine and Health after an extensive international search. 

22 September 2017

Robert Storr’s donation is the gift that keeps on giving

The world-renowned Storr Liver Centre, established from the generous bequest of Robert Storr, has made ground-breaking advancements in the fight against liver cancer and the prevention and treatment of liver disease.

12 September 2017

Standard care for breast cancer trials not always standard

New research has found that some breast cancer trials are failing to provide appropriate control group treatments, affecting the outcomes of these studies.

31 August 2017

3 questions to ask about calls to widen breast cancer screening

With cancer screening, its benefits – less risk of dying of cancer – are clear, and are easily exaggerated. But the potential harms of screening are harder to recognise and readily overlooked, writes Professor Alexandra Barratt.